TIGECYCLINE MAY SELECTIVELY TARGET LEUKEMIC STEM CELLS IN CML

被引：0
|
作者：
Kuntz, E. M.
Baquero, P.
Michie, A. M.
Dunn, K.
Tardito, S.
Holyoake, T. L.
机构：
来源：
CANCER DISCOVERY | 2017年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1212 / 1212
页数：1
相关论文
共 50 条
  • [1] Relapse after allogeneic BMT for CML may be sustained by a low number of leukemic ''stem cells''.
    Podesta, M
    Piaggio, G
    Pitto, A
    Fugazza, G
    Mordini, N
    Berisso, G
    Soracco, M
    Sessarego, M
    Zikos, P
    Bacigalupo, A
    Frassoni, F
    BLOOD, 1997, 90 (10) : 4011 - 4011
  • [2] Modulators of histone demethylase JMJD1C selectively target leukemic stem cells
    Yang, Yong
    Zhang, Xinjing
    Zhang, Xiaoyan
    Wang, Yishu
    Wang, Xintong
    Hu, Linda
    Zhao, Yao
    Wang, Haihua
    Wang, Zhanju
    Wang, Haiying
    Wang, Lin
    Dirks, Wilhelm G.
    Drexler, Hans G.
    Xu, Xin
    Hu, Zhenbo
    FEBS OPEN BIO, 2021, 11 (01): : 265 - 277
  • [3] Right on target: eradicating leukemic stem cells
    Krause, Daniela S.
    Van Etten, Richard A.
    TRENDS IN MOLECULAR MEDICINE, 2007, 13 (11) : 470 - 481
  • [4] SEROTONIN RECEPTOR ANTAGONISM SELECTIVELY TARGETS LEUKEMIC STEM CELLS
    Kahn, Alissa
    Hartwell, Kimberly
    Miller, Peter
    Ebert, Benjamin
    Golub, Todd
    Moore, Malcolm
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1014 - 1014
  • [5] Fluorouracil Selectively Enriches Stem-like Leukemic Cells in a Leukemic Cell Line
    Zhang, Ling
    Yang, Song
    He, Yu-Juan
    Shao, Hui-Yuan
    Wang, Li
    Chen, Hui
    Gao, Yu-Jie
    Qing, Feng-Xian
    Chen, Xian-Chun
    Zhao, Liu-Yang
    Tan, Shi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2010, 6 (05): : 419 - 427
  • [6] Can we finally target the leukemic stem cells?
    Jordan, Craig T.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (04) : 615 - 620
  • [7] Can we selectively target AML stem cells?
    Jordan, Craig T.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [8] Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic ‘stem cells’: a hypothesis
    F Frassoni
    M Podestà
    G Piaggio
    A Pitto
    O Figari
    M Soracco
    MT van Lint
    G Fugazza
    M Sessarego
    A Bacigalupo
    Bone Marrow Transplantation, 1999, 24 : 689 - 691
  • [9] Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells':: a hypothesis
    Frassoni, F
    Podestà, M
    Piaggio, G
    Pitto, A
    Figari, O
    Soracco, M
    van Lint, MT
    Fugazza, G
    Sessarego, M
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 1999, 24 (06) : 689 - 691
  • [10] Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
    Valent, Peter
    Sadovnik, Irina
    Eisenwort, Gregor
    Bauer, Karin
    Herrmann, Harald
    Gleixner, Karoline V.
    Schulenburg, Axel
    Rabitsch, Werner
    Sperr, Wolfgang R.
    Wolf, Dominik
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
12345